Gastrointestinal Cancer News

Long-term use of aspirin was associated with a reduced risk for colorectal cancer, but an increased risk for gastrointestinal bleeding, highlighting the need to weigh the risks and benefits of prophylactic aspirin use, according to data presented at the Gastrointestinal Cancers Symposium.

The investigational hallucinogenic drug psilocybin reduced clinician- and patient-reported depression, anxiety and mortality-associated anxiety among adults with cancer, according to results of a small double blind study.

Fewer than half of childhood cancer survivors receive recommended long-term follow-up care, according to findings of a study led by researchers at Roswell Park Cancer Institute.

Promotion of fecal immunochemical testing by community health workers was successful in increasing screening rates among Haitians and Hispanics, according to findings published in JAMA Internal Medicine.

Stivarga was safe and improved overall survival for patients with unresectable hepatocellular carcinoma, according to data from the RESORCE clinical trial recently published in The Lancet.

Patients who have a false positive Cologuard test result followed by a negative colonoscopy did not have higher rates of subsequent cancer or death compared with true negative patients, according to results from the LONG-HAUL cohort study.

Most adults who received elevated direct-to-consumer personal genomic testing to detect risk for single nucleotide polymorphism–based cancer were not more likely to undergo cancer screening or change their lifestyle, according to results of the Impact of Personal Genomics Study.

Diane M. Simeone , MD, a pancreatic cancer surgeon and researcher, will join NYU Langone’s Perlmutter Cancer Center on March 1.

Families of patients with lung cancer or colorectal cancer reported that their family member had improved end-of-life care and better symptom relief before death while in hospice care, according to published findings in the Journal of Clinical Oncology.

An estimated 34.8 million American men aged 18 to 59 years are infected with some form of genital HPV and one in four men have high-risk HPV, according to a National Health and Nutrition Examination Survey reported in JAMA Oncology.